Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
摘要
<p>Drug products for use in treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.</p>
申请公布号
EP2116258(A1)
申请公布日期
2009.11.11
申请号
EP20090164605
申请日期
2006.08.30
申请人
SCHERING CORPORATION;THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTATIVE NATIONAL INSTITUTES OF HEALTH
发明人
CUA, DANIEL J.;KASTELEIN, ROBERT, A.;TSAI, VAN, T.;CASPI, RACHEL;SILVER, PHYLLIS;LUGER, DROR
